We are live on ! Find out more
TERN

Terns Pharmaceuticals

Delisted

TERN was delisted on the 4th of May, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$26.8M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$19.8M -$1.1M -132,177 -5%
VC
3
Vivo Capital
California
$18.9M
DM
4
Deerfield Management
New York
$16.6M
SCM
5
Suvretta Capital Management
New York
$8.76M +$942K +113,064 +10%
AC
6
Antara Capital
New York
$6.71M +$1.46M +175,000 +23%
BlackRock
7
BlackRock
New York
$5.27M +$1.19M +142,979 +24%
Vanguard Group
8
Vanguard Group
Pennsylvania
$3.95M +$980K +117,655 +27%
SB
9
Samsara BioCapital
California
$2.04M
Geode Capital Management
10
Geode Capital Management
Massachusetts
$1.28M -$103K -12,401 -6%
State Street
11
State Street
Massachusetts
$1.15M +$97.3K +11,679 +8%
Northern Trust
12
Northern Trust
Illinois
$792K -$40.6K -4,880 -4%
BCM
13
Bridgeway Capital Management
Texas
$675K +$795K +95,500 New
Morgan Stanley
14
Morgan Stanley
New York
$632K +$528K +63,412 +243%
CCM
15
CAAS Capital Management
New York
$607K
CAC
16
Cowen and Company
New York
$601K
Jacobs Levy Equity Management
17
Jacobs Levy Equity Management
New Jersey
$390K -$269K -32,312 -37%
Millennium Management
18
Millennium Management
New York
$377K +$444K +53,281 New
Bank of New York Mellon
19
Bank of New York Mellon
New York
$253K +$68.2K +8,187 +30%
Charles Schwab
20
Charles Schwab
California
$204K -$23.3K -2,797 -9%
MAM
21
Marquette Asset Management
Minnesota
$117K +$138K +16,619 New
Goldman Sachs
22
Goldman Sachs
New York
$108K +$127K +15,208 New
PPA
23
Parametric Portfolio Associates
Washington
$87K +$103K +12,317 New
Nuveen
24
Nuveen
North Carolina
$83K
Deutsche Bank
25
Deutsche Bank
Germany
$63K +$3.66K +440 +5%